Felipe Echeverri Tribin, MS; Caroline Lieux, MD; Jorge Maestre-Mesa, MD, PhD; et al.
JAMA Ophthalmol. 2024;142(5):407-415. doi:10.1001/jamaophthalmol.2024.0259
This case series describes the clinical course, outcomes, and microbiological diagnostic profiles of multidrug-resistant Pseudomonas aeruginosa keratitis and the use of rose bengal–photodynamic antimicrobial therapy as an alternative or adjunctive therapy to treat isolates.
-
Invited Commentary
Extensively Drug-Resistant Pseudomonas and Eye Drops—Stay Vigilant
Lauren J. Jeang, MD; Sonal S. Tuli, MD, MEd
JAMA Ophthalmol
Writing Committee for the Pediatric Eye Disease Investigator Group; Pediatric Eye Disease Investigator Group
JAMA Ophthalmol. 2024;142(5):417-428. doi:10.1001/jamaophthalmol.2024.0276
This extension of the Trial of Overminus Spectacle Therapy for Intermittent Exotropia compares refractive error change over 3 years in children with intermittent exotropia originally treated with overminus vs nonoverminus spectacles.
Ogul E. Uner, MD; Dongseok Choi, PhD; Thomas S. Hwang, MD; et al.
JAMA Ophthalmol. 2024;142(5):429-435. doi:10.1001/jamaophthalmol.2024.0394
This study describes the adoption of bias reduction practices in underrepresented groups in ophthalmology residency recruitment and attempts to determines which practices are effective for increasing these residents.
-
Invited Commentary
The Challenge in Building Diverse Ophthalmology Residency Programs
Julius T. Oatts, MD; Neeti Parikh, MD; Saras Ramanathan, MD
JAMA Ophthalmol
Yu Jing Liang, BSc; Yu Yao Wang, MMed; Shi Song Rong, PhD; et al.
JAMA Ophthalmol. 2024;142(5):437-444. doi:10.1001/jamaophthalmol.2024.0363
This systematic review and meta-analysis evaluates associations of common single-nucleotide variants and rare coding variants with primary angle-closure disease.
Jonathan Thomas, BS; Louay Almidani, MD, MSc; Bonnielin K. Swenor, PhD, MPH; et al.
JAMA Ophthalmol. 2024;142(5):445-452. doi:10.1001/jamaophthalmol.2024.0467
This cross-sectional study investigates the association between visual impairment and digital technology access measures in older adults.
-
Invited Commentary
The Digital Divide in Eye Health Care Delivery
Brian C. Stagg, MD, MS; Chelsey R. Schlechter, PhD, MPH; Guilherme Del Fiol, MD, PhD
JAMA Ophthalmol
Nora E. Siegler, BA; Hannah L. Walsh, BS; Kara M. Cavuoto, MD
JAMA Ophthalmol. 2024;142(5):454-461. doi:10.1001/jamaophthalmol.2024.0612
This cross-sectional study investigates the association between geographic distribution of pediatric eye care practitioners and US population demographics in 2023.
-
Invited Commentary
Mapping the Pediatric Eye Care Deserts in the US—A Call for Action
Olivia Bass, OD; Alejandra G. de Alba Campomanes, MD, MPH
JAMA Ophthalmol
Stéphanie S. Cornelis, MSc; Joanna IntHout, PhD; Esmee H. Runhart, MD, PhD; et al.
JAMA Ophthalmol. 2024;142(5):463-471. doi:10.1001/jamaophthalmol.2024.0660
This meta-analysis examines data for patients with Stargardt disease, an ABCA4-associated retinopathy, to investigate whether women are overrepresented in different groups of this patient population.